Genmab A/S (Nasdaq Copenhagen: GMAB.CO) closed at 2,167.00 DKK, +0.4%, on 2026-08-27, with a return on equity of 17.5%, a net margin of 25.9% and 3-year sales growth of -36.5%. Institutional ownership, earnings history and filed financials are on the tabs below.
Fewer than 4 quarters available; TTM falls back to the latest annual figure.
Financials are reported in USD; the price is in DKK (the listing's quote basis differs from the reporting currency — an ADR over a non-USD reporter, or a native venue quoting in a sub-unit like pence). Price-based valuation (market cap, P/E, EV multiples, yields, WACC, and the market-cap-dependent Altman/Merton scores) is suppressed to avoid a cross-currency number. Currency-neutral ratios and returns are unaffected.
full derived coverage requires a plan
Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.
— Months · distinct values (the real sample size).
Metric
Today
Own median
Own range
%ile
z
Sector med.
mo · distinct
P/E (FY)
—
P/E and EPS growth are reconstructed for US-domestic 10-K filers only — a 20-F/40-F foreign private issuer's ADR trades in USD while its EPS is reported in the native currency, so no multiple is reconstructed rather than a wrong one.
17.5%
17.5%
no band (52 mo · 5 distinct)
—
—
—
52 · 5
12.9%
24.0%
no band (52 mo · 5 distinct)
—
—
—
52 · 5
25.9%
35.1%
no band (52 mo · 5 distinct)
—
—
—
52 · 5
27.4%
17.0%
57th
−0.07σ
—
141 · 139
EPS Growth 3Y (FY)
−42.9%
only 2 monthly observations — under the 12-month floor for a series line. P/E and EPS growth are reconstructed for US-domestic 10-K filers only — a 20-F/40-F foreign private issuer's ADR trades in USD while its EPS is reported in the native currency, so no multiple is reconstructed rather than a wrong one.
−36.5%
—
no band (16 mo · 2 distinct)
—
—
—
16 · 2
Market Cap
—
not reconstructed — market cap was removed from the historical pass (never a ranking factor, and a reconstructed share count carries look-ahead risk). The single stored value is the forward-captured snapshot, not a series.
ROE (point-in-time)shaded = own p10–p90 · dashed = own median · right-edge tick = today
shown for reference only — the reconstructed distribution did not clear the band gate, so no rank is quoted.
Multiple-implied price ladder · Full
Filed earnings only.
no P/E ladder — P/E and EPS growth are reconstructed for US-domestic 10-K filers only — a 20-F/40-F foreign private issuer's ADR trades in USD while its EPS is reported in the native currency, so no multiple is reconstructed rather than a wrong one.
Ladder not drawn for this name — the reason is above.ⓘ
Not a forecast: each row re-prices today's filed earnings at a multiple this company itself once traded at. It abstains rather than guess on a loss year or a broken per-share basis.
Every month uses only what was filed by then, split-adjusted. Delisted names are absent and a trough year can throw one huge reading, so read the median, not the edges.
Percentile through time (point-in-time cohort)
Loading the monthly cohort placement…
▸Comp setname your own peers — pick a pool or add tickers
vs peers
This scope ranks once the pool is big enough to mean something: no sector classification for this name.
Industry structureindustry pool pending for GMAB.CO
This company's industry pool year publishes once its group is tagged, its annual revenue is stored and the newest year clears the filing-alignment guard. A coverage gap, never a statement about the company.
